Skip to main content
. 2022 Mar 17;9(5):ofac133. doi: 10.1093/ofid/ofac133

Table 1.

Patient Characteristics for the Study Population, Queensland 2012–2016

No. Female, % Age (SD), y Died in Hospital, No. (%) LOS, Median (IQR), d Incidence/100 000
S. aureus All R 215 32.6 58.8 (26.8) 16 (7.4) 13 (6–25) 1.2
S 1300 34.9 59.7 (24.0) 104 (8.0) 13 (6–26) 7.5
BSI R 135 32.6 52.3 (25.8) 9 (6.7) 18 (10–32) 0.8
S 882 31.7 58.8 (23.7) 81 (9.2) 17 (9–32) 5.1
UTI R 80 32.5 69.8 (24.9) 7 (8.8) 6.5 (4–12.3) 0.5
S 418 41.6 61.6 (24.7) 23 (5.5) 6 (3–12) 2.4
E. faecium All R 77 71.4 71.9 (16.1) 4 (5.2) 7 (4–11) 0.4
S 121 62.8 71.4 (20.6) 6 (5.0) 7 (4–13) 0.7
BSI R 3 0.0 78.0 (1.7) 0 (0.0) 11 (8.5–11) 0.0
S 20 35.0 62.2 (25.2) 0 (0.0) 13 (7.8–17.3) 0.1
UTI R 74 74.3 71.7 (16.3) 4 (5.4) 6.5 (4–10.7) 0.4
S 101 68.3 73.2 (19.1) 6 (5.9) 7 (4–11) 0.6
Enterobacteriaceae All R 489 65.8 68.1 (22.8) 27 (5.5) 6 (4–11) 2.8
S 15 267 76.4 67.0 (24.1) 507 (3.3) 5 (3–9) 87.5
BSI R 63 42.9 71.2 (15.9) 9 (14.3) 8 (6–12.5) 0.4
S 1446 51.7 66.4 (21.4) 66 (4.6) 7 (4–10) 8.3
UTI R 426 69.2 67.7 (23.6) 18 (4.2) 6 (3–11) 2.4
S 13821 79.0 67.1 (24.3) 441 (3.2) 5 (3–9) 79.2
P. aeruginosa All R 298 39.6 66.5 (20.5) 17 (5.7) 8 (4–13) 1.7
S 3501 44.8 70.5 (20.0) 189 (5.4) 6 (4–12) 20.1
BSI R 7 42.9 67.4 (26.9) 0 (0.0) 9 (4–12.5) 0.0
S 147 25.9 70.4 (18.1) 12 (8.2) 8 (5–18.8) 0.8
UTI R 95 36.8 77.5 (13.5) 11 (11.6) 6 (3–12.5) 0.5
S 1722 48.4 73.3 (20.4) 75 (4.4) 6 (3–11) 9.9
Resp R 196 40.8 61.1 (21.0) 6 (3.1) 9 (4–13) 1.1
S 1632 42.8 67.6 (19.3) 102 (6.3) 7 (4–12) 9.4

Due to the low number of patients (Table 1), we excluded the E. faecium BSI and P. aeruginosa BSI infection groups from the regression analyses (Table 2).

Abbreviations: BSI, bloodstream infection; IQR, interquartile range; LOS, length of stay; R, drug-resistant; Res, respiratory tract infection; S, drug-sensitive; UTI, urinary tract infection.